Showing results (141-150 of 174) with videos related to
Sort By:
Pageof 18
European Journal of Clinical Investigation|June 1, 1991
Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in manP Toulon, G Chadeuf, J L Bouillot, et al.American Journal of Hematology|March 1, 1987
A variant of type II von Willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von Willebrand factor structureH R Gralnick, S B Williams, L P McKeown, et al.Human Genetics|November 1, 1986
De novo mutation in hemophilia A established by DNA haplotype analysis and precluding prenatal diagnosisM Delpech, N Deburgrave, M Baudis, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|January 13, 2000
Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. secretariat.haemophiles@cch.ap-hop-paris.frP Molho, N Rolland, T Lebrun, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosisP Molho, P Verrier, N Stieltjes, et al.Vox Sanguinis|October 9, 2002
Polystyrene derivatives as candidates for extracorporeal adsorption of Factor VIII antibodies in the management of haemophiliac patientsC Boisson-Vidal, M Haouam, H Lakhiari, et al.Antimicrobial Agents and Chemotherapy|May 29, 1999
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistanceN I Girgis, T Butler, R W Frenck, et al.Thrombosis and Haemostasis|November 2, 1999
Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrateA Parquet, Y Laurian, C Rothschild, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1985
In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's diseaseH R Gralnick, S B Williams, L P McKeown, et al.Blood|February 1, 1986
DDAVP in type IIa von Willebrand's diseaseH R Gralnick, S B Williams, L P McKeown, et al.Pageof 18